Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review

Foran, Terri; Butcher, Belinda; Kovacs, Gab; Bateson, Deborah; O’Connor, Vivienne

doi:10.1080/13625187.2018.1526898

Cited by 30 publications

(24 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Placement can sometimes be painful, but the procedure is fast [104]. A copper-bearing IUD can also be inserted as an emergency contraceptive method within 120 h from unprotected sexual intercourse [105].…”

Section: Intrauterine Devices (Iud)mentioning

confidence: 99%

Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology

et al. 2020

View full text Add to dashboard Cite

Even though fertility is reduced, conception and delivery are possible in all stages of CKD. While successful planned pregnancies are increasing, an unwanted pregnancy may have long-lasting deleterious effects, hence the importance of birth control, an issue often disregarded in clinical practice. The evidence summarized in this position statement is mainly derived from the overall population, or other patient categories, in the lack of guidelines specifically addressed to CKD. Oestroprogestagents can be used in early, non-proteinuric CKD, excluding SLE and immunologic disorders, at high risk of thromboembolism and hypertension. Conversely, progestin only is generally safe and its main side effect is intramestrual spotting. Non-medicated intrauterine devices are a good alternative; their use needs to be carefully evaluated in patients at a high risk of pelvic infection, even though the degree of risk remains controversial. Barrier methods, relatively efficacious when correctly used, have few risks, and condoms are the only contraceptives that protect against sexually transmitted diseases. Surgical sterilization is rarely used also because of the risks surgery involves; it is not definitely contraindicated, and may be considered in selected cases. Emergency contraception with high-dose progestins or intrauterine devices is not contraindicated but should be avoided whenever possible, even if far preferable to abortion. Surgical abortion is invasive, but experience with medical abortion in CKD is still limited, especially in the late stages of the disease. In summary, personalized contraception is feasible, safe and should be offered to all CKD women of childbearing age who do not want to get pregnant.

show abstract

Section: Intrauterine Devices (Iud)mentioning

confidence: 99%

Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Previous studies have reported, however, that intrauterine contraception has no effect on fertility once the method is stopped. 21,22 Women's perceptions of LARCs in the PULSE study also suggested a lack of knowledge regarding these methods. 17 Additionally, the comfort and confidence a woman feels when speaking to her healthcare provider may play a role in their openness to have conversations about their requirements and opinions of a variety of birth control methods.…”

Section: Adoptionmentioning

confidence: 99%

From awareness to usage of long‐acting reversible contraceptives: Results of a large European survey

Caetano

Bliekendaal²,

Engler

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Objective: The PULSE survey investigated contraceptive decision making, focusing on the use of long-acting reversible contraceptives (LARCs) to determine reasons for their low adoption rates. Methods: An online questionnaire was sent to women aged 18-49 years in 14 European countries who were considering starting or changing contraceptive method and asked questions based on four stages of contraceptive decision making: awareness, consideration, consultation, and adoption. Results: Overall, 7221 women responded. LARC awareness was high (~73%) but current usage was low (11.3%). Only 24% of LARC-aware women would consider switching to them. Factors associated with decision making differed depending on the stage: e.g. at the awareness phase, women were concerned with suitability, reversibility, and whether the method is hormonal; and at the consideration phase, the efficacy, convenience, and adverse-effect profile were important. Healthcare professionals (HCPs) were the most trusted information source for women's contraceptive decision making. LARCs were discussed less frequently during consultations than other contraceptives and HCPs may be perceived to hold negative opinions on LARCs. Conclusion: A lack of knowledge about the features and benefits of LARCs can contribute to misconceptions and low adoption rates. HCPs play an important role in addressing this, as information conveyed during consultations influences women's contraceptive choices.

show abstract

“…Among the disadvantages of LARCs is that insertion is uncomfortable and sometimes painful, particularly among nulliparous women (Foran, Butcher, Kovacs, Bateson, & O'Connor, 2018), and the most effective method of pain control has not yet been established (see review in American College of Obstetrics and Gynecology, May 2018, pp. e134-135).…”

Section: Disadvantages Of Larcsmentioning

confidence: 99%

Long‐acting reversible contraception: A route to reproductive justice or injustice

Kaitz

Mankuta²,

Mankuta

2019

Infant Mental Health Journal

View full text Add to dashboard Cite

This article presents information on unintended pregnancies and the ongoing efforts of policy makers to promote long‐acting reversible contraception (LARC) to reduce the numbers of such pregnancies. Also discussed is the tension between the encouragement of LARC to promote the public's interests in achieving that goal versus the need to assure that all women can decide about their bodies and reproductive needs. Our discussion includes information, primarily from the United States, on (a) risks associated with unintended pregnancies, (b) LARC devices approved in the United States (copper intrauterine devices (IUDs), hormone IUDs, and implants), (c) public and social benefits of increasing the use of LARC, (d) disadvantages and barriers to using LARC, (e) dangers of promoting LARC in unjust ways, and (f) the meaning of reproductive justice and its connection to social justice. By sharing the information with the audience of this journal, we hope that it will be integrated into clinical work and research on mental health and development. We also hope that experts in those fields will become discussants in the conversation regarding women's reproductive health and social justice that is taking place in the United States and elsewhere.

show abstract

Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review

Cited by 30 publications

References 62 publications

Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology

Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology

From awareness to usage of long‐acting reversible contraceptives: Results of a large European survey

Long‐acting reversible contraception: A route to reproductive justice or injustice

Contact Info

Product

Resources

About